MedTrace Logo

Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics

NCT00721097 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2013-09-30

No results posted yet for this study

Summary

Asthma is a chronic inflammatory disease, affecting up to 10 % of the general population in developed countries. Corticosteroids are necessary to control symptoms, but induce adverse events sometimes intolerable. In severe asthma, which represent 5 to 10% of global asthma, corticosteroids frequently fail to prevent severe exacerbations, leading to emergency care, hospitalization and sometimes death. The aim of this study is to identify predictive factors specific for exacerbation outcome which will lead to a minor increase in treatment in order to prevent exacerbations, while minimizing drug adverse effects.

Conditions

Interventions

OTHER

spirometry, and blood taken

each month during one year

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Antoine MAGNAN, MD · Nantes University Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00721097 on ClinicalTrials.gov